Skip to main content

Echocardiographic Signs of Pulmonary Hypertension (PH)


Echocardiographic Signs of Pulmonary Hypertension (PH)


1. Elevated Pulmonary Artery Systolic Pressure (PASP)


Most important screening parameter.


Estimated from TR Jet Velocity:


PASP = 4(V_{TR})^2 + RAP


TR velocity >2.8–3.4 m/s suggests PH


Higher velocity → higher probability of PH




---


2. Right Ventricular (RV) Changes


RV dilatation


RV hypertrophy (RV free wall >5 mm)


Reduced RV systolic function


RV pressure overload pattern



Severe PH:


RV larger than LV


Reduced TAPSE


Reduced RV FAC




---


3. Interventricular Septal Flattening


Due to RV pressure overload.


D-shaped LV in PSAX


Systolic flattening → pressure overload


Diastolic flattening → volume overload




---


4. Right Atrial Enlargement


Enlarged RA area


Dilated IVC with reduced collapse



Suggests elevated right-sided pressures.



---


5. Pulmonary Artery Abnormalities


Dilated main pulmonary artery


PA diameter >25 mm


Early systolic notching on RVOT Doppler




---


6. Shortened Pulmonary Acceleration Time (PAT)


RVOT PW Doppler:


PAT <105 ms suggests PH


Mid-systolic notching may be present




---


7. Increased Right Atrial Pressure (RAP)


IVC findings:


Dilated IVC (>2.1 cm)


Poor inspiratory collapse (<50%)




---


8. Secondary TR / PR


Functional tricuspid regurgitation


Pulmonary regurgitation may increase with severe PH




---


9. Reduced LV Size


Due to RV pressure overload and septal shift.


Small underfilled LV may be seen in advanced PH.



---


Echo Probability of PH (ESC/ERS Concept)


Low Probability


TR velocity ≤2.8 m/s


No additional PH signs



Intermediate Probability


TR velocity 2.9–3.4 m/s with other PH signs



High Probability


TR velocity >3.4 m/s OR


TR velocity 2.9–3.4 m/s + multiple supportive signs




---


Important Supportive Echo Findings


RV enlargement


RA enlargement


D-shaped LV


Dilated PA


Short PAT


Dilated IVC


RV dysfunction




---


Gold Standard


Echo suggests probability only.


Definitive diagnosis:


Right heart catheterization (RHC).



Comments

Popular posts from this blog

π˜Όπ™£π™©π™žπ™˜π™€π™–π™œπ™ͺπ™‘π™–π™©π™žπ™€π™£ π˜Όπ™›π™©π™šπ™§ π™Žπ™©π™§π™€π™ π™š

 π˜Όπ™£π™©π™žπ™˜π™€π™–π™œπ™ͺπ™‘π™–π™©π™žπ™€π™£ π˜Όπ™›π™©π™šπ™§ π™Žπ™©π™§π™€π™ π™š in  Patient with AF and acute IS/TIA European Heart Association Guideline recommends: • 1 days after TIA • 3 days after mild stroke • 6 days after moderate stroke • 12 days after severe stroke Early anticoagulation can decrease a risk of recurrent stroke and embolic events but may increase a risk of secondary hemorrhagic transformation of brain infarcts.  The 1-3-6-12-day rule is a known consensus with graded increase in delay of anticoagulation between 1 and 12 days after onset of ischemic stroke or transient ischemic attack(TIA), according to neurological severity based on European expert opinions. However, this rule might be somewhat later than currently used in a real-world practical setting.

Acute Treatment of Hyperkalemia

Acute Treatment of Hyperkalemia – A Practical, Bedside-Oriented Guide Hyperkalemia is a potentially life-threatening electrolyte abnormality that demands prompt recognition and decisive management. The danger lies not only in the absolute potassium value but in its effects on cardiac conduction, which can rapidly progress to fatal arrhythmias. Acute treatment focuses on three parallel goals: stabilizing the cardiac membrane, shifting potassium into cells, and removing excess potassium from the body. Understanding this stepwise approach helps clinicians act quickly and rationally in emergency settings. Why Hyperkalemia Is Dangerous Potassium plays a key role in maintaining the resting membrane potential of cardiac myocytes. Elevated serum potassium reduces the transmembrane gradient, leading to slowed conduction, ECG changes, ventricular arrhythmias, and asystole. Importantly, ECG changes do not always correlate with potassium levels, so treatment decisions should be based on clinical c...

2025 AHA/ACC Hypertension Guidelines Key points

  2025 AHA/ACC Hypertension Guidelines Explained: A Clear Summary for Clinicians and Students Hypertension remains one of the most significant contributors to cardiovascular morbidity and mortality worldwide. With continual refinement of evidence and risk-based strategies, the 2025 AHA/ACC Hypertension Guidelines bring an updated, practical approach that clinicians can use in daily practice. To make learning easier, I’ve created a clean and modern infographic summarizing all major recommendations. You can download it below and use it for study, teaching, or clinical reference. Download Infographic (PNG): 2025 Hypertension Guideline Infographic This post breaks down the key points from the guidelines and complements the infographic for a complete understanding. --- BP Categories: Understanding the Updated Thresholds The guidelines maintain the well-established classification of blood pressure: Normal: <120 / <80 Elevated: 120–129 / <80 Stage 1 Hypertension: 130–139 and/or 8...